Clinical trial

SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA)

NCT02419508

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-08-07

PhasePHASE4

Study timeline

Study start (actual)2015-08-07Date precision: day

Registry last updated2018-11-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Open-Angle Glaucomaunresolved

Ocular Hypertensionunresolved

Interventions

Brinzolamide 1%/brimonidine 0.2% tartrate ophthalmic suspensionDRUG

Brinz/brim vehicleDRUG

Prostaglandin analogueDRUG

Sponsors & collaborators

Alcon Researchlead sponsor

Mapped research locations

Fort WorthTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02419508 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.